Defining the source and role of TGFβ particularly in the stroma to promote EMT and metastasis, and in the distinct immune cell types, including CD4+ , CD8+T cells, NK or dendritic cells [254], has provided much renewed faith in therapeutic targeting of TGFβ in cancer. The gene discussed is TGFB1; the disease is cancer.